From genome to therapy: integrating new technologies with drug development
Gespeichert in:
| Weitere Verfasser: | , , |
|---|---|
| Format: | Tagungsbericht Buch |
| Sprache: | English |
| Veröffentlicht: |
Chichester ; Weinheim [u.a.]
John Wiley
2000
|
| Schriftenreihe: | Novartis Foundation symposium
229 |
| Schlagworte: | |
| Beschreibung: | "Symposium on From Genome to Therapy: Integrating New Technologies with Drug Development, held at the Hotel Europe, Basel, Switzerland, 22-24 June 1999"--Contents p - Includes bibliographical references and index |
| Beschreibung: | VIII, 165 S. graph. Darst. |
| ISBN: | 0471627445 |
Internformat
MARC
| LEADER | 00000nam a2200000 cb4500 | ||
|---|---|---|---|
| 001 | BV021479578 | ||
| 003 | DE-604 | ||
| 005 | 20010308 | ||
| 007 | t | ||
| 008 | 001020s2000 d||| |||| 00||| eng d | ||
| 020 | |a 0471627445 |c (alk. paper) |9 0-471-62744-5 | ||
| 035 | |a (DE-599)BVBBV021479578 | ||
| 040 | |a DE-604 |b ger |e rakwb | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-M382 | ||
| 245 | 1 | 0 | |a From genome to therapy |b integrating new technologies with drug development |c [editors: Gregory R. Bock, Dalia Cohen, and Jamie A. Goode] |
| 264 | 1 | |a Chichester ; Weinheim [u.a.] |b John Wiley |c 2000 | |
| 300 | |a VIII, 165 S. |b graph. Darst. | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b n |2 rdamedia | ||
| 338 | |b nc |2 rdacarrier | ||
| 490 | 1 | |a Novartis Foundation symposium |v 229 | |
| 500 | |a "Symposium on From Genome to Therapy: Integrating New Technologies with Drug Development, held at the Hotel Europe, Basel, Switzerland, 22-24 June 1999"--Contents p - Includes bibliographical references and index | ||
| 650 | 0 | 7 | |a Pharmakogenetik |0 (DE-588)4271255-5 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Genanalyse |0 (DE-588)4200230-8 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Arzneimittelentwicklung |0 (DE-588)4143176-5 |2 gnd |9 rswk-swf |
| 655 | 7 | |8 1\p |0 (DE-588)1071861417 |a Konferenzschrift |y 1999 |z Basel |2 gnd-content | |
| 655 | 7 | |8 2\p |0 (DE-588)1071861417 |a Konferenzschrift |2 gnd-content | |
| 689 | 0 | 0 | |a Genanalyse |0 (DE-588)4200230-8 |D s |
| 689 | 0 | 1 | |a Arzneimittelentwicklung |0 (DE-588)4143176-5 |D s |
| 689 | 0 | |8 3\p |5 DE-604 | |
| 689 | 1 | 0 | |a Pharmakogenetik |0 (DE-588)4271255-5 |D s |
| 689 | 1 | 1 | |a Arzneimittelentwicklung |0 (DE-588)4143176-5 |D s |
| 689 | 1 | |8 4\p |5 DE-604 | |
| 700 | 1 | |a Bock, Gregory |4 edt | |
| 700 | 1 | |a Cohen, Dalia |4 edt | |
| 700 | 1 | |a Goode, Jamie A. |4 edt | |
| 710 | 2 | |a Novartis Foundation |e Sonstige |0 (DE-588)5251089-X |4 oth | |
| 711 | 2 | |a Symposium on From Genome to Therapy: Integrating New Technologies with Drug Development |d 1999 |c Basel |j Sonstige |0 (DE-588)5519928-8 |4 oth | |
| 830 | 0 | |a Novartis Foundation symposium |v 229 |w (DE-604)BV011990857 | |
| 999 | |a oai:aleph.bib-bvb.de:BVB01-014700700 | ||
| 883 | 1 | |8 1\p |a cgwrk |d 20201028 |q DE-101 |u https://d-nb.info/provenance/plan#cgwrk | |
| 883 | 1 | |8 2\p |a cgwrk |d 20201028 |q DE-101 |u https://d-nb.info/provenance/plan#cgwrk | |
| 883 | 1 | |8 3\p |a cgwrk |d 20201028 |q DE-101 |u https://d-nb.info/provenance/plan#cgwrk | |
| 883 | 1 | |8 4\p |a cgwrk |d 20201028 |q DE-101 |u https://d-nb.info/provenance/plan#cgwrk | |
Datensatz im Suchindex
| _version_ | 1804135207967653888 |
|---|---|
| adam_txt | |
| any_adam_object | |
| any_adam_object_boolean | |
| author2 | Bock, Gregory Cohen, Dalia Goode, Jamie A. |
| author2_role | edt edt edt |
| author2_variant | g b gb d c dc j a g ja jag |
| author_facet | Bock, Gregory Cohen, Dalia Goode, Jamie A. |
| building | Verbundindex |
| bvnumber | BV021479578 |
| ctrlnum | (DE-599)BVBBV021479578 |
| format | Conference Proceeding Book |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>02406nam a2200505 cb4500</leader><controlfield tag="001">BV021479578</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20010308 </controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">001020s2000 d||| |||| 00||| eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">0471627445</subfield><subfield code="c">(alk. paper)</subfield><subfield code="9">0-471-62744-5</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV021479578</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-M382</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">From genome to therapy</subfield><subfield code="b">integrating new technologies with drug development</subfield><subfield code="c">[editors: Gregory R. Bock, Dalia Cohen, and Jamie A. Goode]</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Chichester ; Weinheim [u.a.]</subfield><subfield code="b">John Wiley</subfield><subfield code="c">2000</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">VIII, 165 S.</subfield><subfield code="b">graph. Darst.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="1" ind2=" "><subfield code="a">Novartis Foundation symposium</subfield><subfield code="v">229</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">"Symposium on From Genome to Therapy: Integrating New Technologies with Drug Development, held at the Hotel Europe, Basel, Switzerland, 22-24 June 1999"--Contents p - Includes bibliographical references and index</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Pharmakogenetik</subfield><subfield code="0">(DE-588)4271255-5</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Genanalyse</subfield><subfield code="0">(DE-588)4200230-8</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Arzneimittelentwicklung</subfield><subfield code="0">(DE-588)4143176-5</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="8">1\p</subfield><subfield code="0">(DE-588)1071861417</subfield><subfield code="a">Konferenzschrift</subfield><subfield code="y">1999</subfield><subfield code="z">Basel</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="8">2\p</subfield><subfield code="0">(DE-588)1071861417</subfield><subfield code="a">Konferenzschrift</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Genanalyse</subfield><subfield code="0">(DE-588)4200230-8</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Arzneimittelentwicklung</subfield><subfield code="0">(DE-588)4143176-5</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="8">3\p</subfield><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="1" ind2="0"><subfield code="a">Pharmakogenetik</subfield><subfield code="0">(DE-588)4271255-5</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2="1"><subfield code="a">Arzneimittelentwicklung</subfield><subfield code="0">(DE-588)4143176-5</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2=" "><subfield code="8">4\p</subfield><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Bock, Gregory</subfield><subfield code="4">edt</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Cohen, Dalia</subfield><subfield code="4">edt</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Goode, Jamie A.</subfield><subfield code="4">edt</subfield></datafield><datafield tag="710" ind1="2" ind2=" "><subfield code="a">Novartis Foundation</subfield><subfield code="e">Sonstige</subfield><subfield code="0">(DE-588)5251089-X</subfield><subfield code="4">oth</subfield></datafield><datafield tag="711" ind1="2" ind2=" "><subfield code="a">Symposium on From Genome to Therapy: Integrating New Technologies with Drug Development</subfield><subfield code="d">1999</subfield><subfield code="c">Basel</subfield><subfield code="j">Sonstige</subfield><subfield code="0">(DE-588)5519928-8</subfield><subfield code="4">oth</subfield></datafield><datafield tag="830" ind1=" " ind2="0"><subfield code="a">Novartis Foundation symposium</subfield><subfield code="v">229</subfield><subfield code="w">(DE-604)BV011990857</subfield><subfield code="9"></subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-014700700</subfield></datafield><datafield tag="883" ind1="1" ind2=" "><subfield code="8">1\p</subfield><subfield code="a">cgwrk</subfield><subfield code="d">20201028</subfield><subfield code="q">DE-101</subfield><subfield code="u">https://d-nb.info/provenance/plan#cgwrk</subfield></datafield><datafield tag="883" ind1="1" ind2=" "><subfield code="8">2\p</subfield><subfield code="a">cgwrk</subfield><subfield code="d">20201028</subfield><subfield code="q">DE-101</subfield><subfield code="u">https://d-nb.info/provenance/plan#cgwrk</subfield></datafield><datafield tag="883" ind1="1" ind2=" "><subfield code="8">3\p</subfield><subfield code="a">cgwrk</subfield><subfield code="d">20201028</subfield><subfield code="q">DE-101</subfield><subfield code="u">https://d-nb.info/provenance/plan#cgwrk</subfield></datafield><datafield tag="883" ind1="1" ind2=" "><subfield code="8">4\p</subfield><subfield code="a">cgwrk</subfield><subfield code="d">20201028</subfield><subfield code="q">DE-101</subfield><subfield code="u">https://d-nb.info/provenance/plan#cgwrk</subfield></datafield></record></collection> |
| genre | 1\p (DE-588)1071861417 Konferenzschrift 1999 Basel gnd-content 2\p (DE-588)1071861417 Konferenzschrift gnd-content |
| genre_facet | Konferenzschrift 1999 Basel Konferenzschrift |
| id | DE-604.BV021479578 |
| illustrated | Illustrated |
| index_date | 2024-07-02T14:10:46Z |
| indexdate | 2024-07-09T20:36:51Z |
| institution | BVB |
| institution_GND | (DE-588)5251089-X (DE-588)5519928-8 |
| isbn | 0471627445 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-014700700 |
| open_access_boolean | |
| owner | DE-M382 |
| owner_facet | DE-M382 |
| physical | VIII, 165 S. graph. Darst. |
| publishDate | 2000 |
| publishDateSearch | 2000 |
| publishDateSort | 2000 |
| publisher | John Wiley |
| record_format | marc |
| series | Novartis Foundation symposium |
| series2 | Novartis Foundation symposium |
| spelling | From genome to therapy integrating new technologies with drug development [editors: Gregory R. Bock, Dalia Cohen, and Jamie A. Goode] Chichester ; Weinheim [u.a.] John Wiley 2000 VIII, 165 S. graph. Darst. txt rdacontent n rdamedia nc rdacarrier Novartis Foundation symposium 229 "Symposium on From Genome to Therapy: Integrating New Technologies with Drug Development, held at the Hotel Europe, Basel, Switzerland, 22-24 June 1999"--Contents p - Includes bibliographical references and index Pharmakogenetik (DE-588)4271255-5 gnd rswk-swf Genanalyse (DE-588)4200230-8 gnd rswk-swf Arzneimittelentwicklung (DE-588)4143176-5 gnd rswk-swf 1\p (DE-588)1071861417 Konferenzschrift 1999 Basel gnd-content 2\p (DE-588)1071861417 Konferenzschrift gnd-content Genanalyse (DE-588)4200230-8 s Arzneimittelentwicklung (DE-588)4143176-5 s 3\p DE-604 Pharmakogenetik (DE-588)4271255-5 s 4\p DE-604 Bock, Gregory edt Cohen, Dalia edt Goode, Jamie A. edt Novartis Foundation Sonstige (DE-588)5251089-X oth Symposium on From Genome to Therapy: Integrating New Technologies with Drug Development 1999 Basel Sonstige (DE-588)5519928-8 oth Novartis Foundation symposium 229 (DE-604)BV011990857 1\p cgwrk 20201028 DE-101 https://d-nb.info/provenance/plan#cgwrk 2\p cgwrk 20201028 DE-101 https://d-nb.info/provenance/plan#cgwrk 3\p cgwrk 20201028 DE-101 https://d-nb.info/provenance/plan#cgwrk 4\p cgwrk 20201028 DE-101 https://d-nb.info/provenance/plan#cgwrk |
| spellingShingle | From genome to therapy integrating new technologies with drug development Novartis Foundation symposium Pharmakogenetik (DE-588)4271255-5 gnd Genanalyse (DE-588)4200230-8 gnd Arzneimittelentwicklung (DE-588)4143176-5 gnd |
| subject_GND | (DE-588)4271255-5 (DE-588)4200230-8 (DE-588)4143176-5 (DE-588)1071861417 |
| title | From genome to therapy integrating new technologies with drug development |
| title_auth | From genome to therapy integrating new technologies with drug development |
| title_exact_search | From genome to therapy integrating new technologies with drug development |
| title_exact_search_txtP | From genome to therapy integrating new technologies with drug development |
| title_full | From genome to therapy integrating new technologies with drug development [editors: Gregory R. Bock, Dalia Cohen, and Jamie A. Goode] |
| title_fullStr | From genome to therapy integrating new technologies with drug development [editors: Gregory R. Bock, Dalia Cohen, and Jamie A. Goode] |
| title_full_unstemmed | From genome to therapy integrating new technologies with drug development [editors: Gregory R. Bock, Dalia Cohen, and Jamie A. Goode] |
| title_short | From genome to therapy |
| title_sort | from genome to therapy integrating new technologies with drug development |
| title_sub | integrating new technologies with drug development |
| topic | Pharmakogenetik (DE-588)4271255-5 gnd Genanalyse (DE-588)4200230-8 gnd Arzneimittelentwicklung (DE-588)4143176-5 gnd |
| topic_facet | Pharmakogenetik Genanalyse Arzneimittelentwicklung Konferenzschrift 1999 Basel Konferenzschrift |
| volume_link | (DE-604)BV011990857 |
| work_keys_str_mv | AT bockgregory fromgenometotherapyintegratingnewtechnologieswithdrugdevelopment AT cohendalia fromgenometotherapyintegratingnewtechnologieswithdrugdevelopment AT goodejamiea fromgenometotherapyintegratingnewtechnologieswithdrugdevelopment AT novartisfoundation fromgenometotherapyintegratingnewtechnologieswithdrugdevelopment AT symposiumonfromgenometotherapyintegratingnewtechnologieswithdrugdevelopmentbasel fromgenometotherapyintegratingnewtechnologieswithdrugdevelopment |